Aeterna’s AEZS-108 final Phase 2 results in endometrial cancer to be presented at ESGO 2011 Aeterna Zentaris Inc. The trial was conducted by the German AGO Study study and Group centers in Bulgaria. AEZS-108, a targeted cytotoxic peptide conjugate, is definitely in Phase 1/2 programs in prostate and bladder cancers currently, and has completed Stage 2 trials in endometrial and ovarian cancers successfully.These extreme climate adjustments allow for longer reproductive lives and prolonged breeding periods, while increasing the risk of contaminated mosquitoes spreading malaria to the U.S. While this is a growing problem for the U.S. There are ways to help prevent the spread of airport terminal malaria. The very best protection against the spread of malaria through worldwide travel is prevention, early detection and treatment of malaria-infected patients, and draining stagnant areas of water where mosquitoes breed and lay eggs, says Dr.